ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41,889 | -27.8% | 1,175 | -6.5% | 0.00% | – |
| Q2 2023 | $57,985 | +56.8% | 1,257 | +36.3% | 0.00% | – |
| Q1 2023 | $36,972 | -15.9% | 922 | -2.8% | 0.00% | – |
| Q4 2022 | $43,967 | +9.9% | 949 | -2.2% | 0.00% | – |
| Q3 2022 | $40,000 | -31.0% | 970 | +0.4% | 0.00% | – |
| Q2 2022 | $58,000 | -26.6% | 966 | -11.7% | 0.00% | – |
| Q1 2022 | $79,000 | -14.1% | 1,094 | -0.5% | 0.00% | – |
| Q4 2021 | $92,000 | -8.9% | 1,099 | -2.3% | 0.00% | -100.0% |
| Q3 2021 | $101,000 | -12.9% | 1,125 | -7.7% | 0.00% | – |
| Q2 2021 | $116,000 | -97.4% | 1,219 | -96.9% | 0.00% | -100.0% |
| Q1 2021 | $4,420,000 | -16.8% | 38,821 | +1.1% | 0.02% | -20.0% |
| Q4 2020 | $5,315,000 | +88.0% | 38,394 | +11.6% | 0.02% | +42.9% |
| Q3 2020 | $2,827,000 | +4.2% | 34,395 | -0.8% | 0.01% | +7.7% |
| Q2 2020 | $2,713,000 | +88.8% | 34,689 | +7.2% | 0.01% | +62.5% |
| Q1 2020 | $1,437,000 | -1.6% | 32,349 | -5.5% | 0.01% | +33.3% |
| Q4 2019 | $1,461,000 | -1.0% | 34,219 | -0.8% | 0.01% | 0.0% |
| Q3 2019 | $1,476,000 | -33.1% | 34,507 | -0.7% | 0.01% | -33.3% |
| Q2 2019 | $2,206,000 | -5.1% | 34,747 | +3.6% | 0.01% | 0.0% |
| Q1 2019 | $2,325,000 | +70.0% | 33,524 | +6.6% | 0.01% | +50.0% |
| Q4 2018 | $1,368,000 | -42.5% | 31,456 | +0.8% | 0.01% | -25.0% |
| Q3 2018 | $2,381,000 | +1.1% | 31,191 | +1.8% | 0.01% | 0.0% |
| Q2 2018 | $2,355,000 | +62.2% | 30,630 | +7.5% | 0.01% | +60.0% |
| Q1 2018 | $1,452,000 | +17.4% | 28,483 | +6.8% | 0.01% | +25.0% |
| Q4 2017 | $1,237,000 | -12.5% | 26,663 | +0.5% | 0.00% | -20.0% |
| Q3 2017 | $1,413,000 | -7.3% | 26,537 | +8.1% | 0.01% | 0.0% |
| Q2 2017 | $1,525,000 | -4.0% | 24,553 | +4.8% | 0.01% | -16.7% |
| Q1 2017 | $1,588,000 | +9.0% | 23,429 | +13.1% | 0.01% | 0.0% |
| Q4 2016 | $1,457,000 | -99.9% | 20,717 | -0.3% | 0.01% | 0.0% |
| Q3 2016 | $1,473,495,000 | +45.3% | 20,771 | +0.1% | 0.01% | +50.0% |
| Q2 2016 | $1,014,393,000 | -28.0% | 20,740 | -6.8% | 0.00% | -33.3% |
| Q1 2016 | $1,409,000,000 | -40.3% | 22,257 | +5.8% | 0.01% | -40.0% |
| Q4 2015 | $2,359,000,000 | +115367.4% | 21,028 | -0.9% | 0.01% | +11.1% |
| Q3 2015 | $2,043,000 | -99.9% | 21,209 | +0.8% | 0.01% | 0.0% |
| Q2 2015 | $2,154,286,000 | +686.2% | 21,040 | +376.8% | 0.01% | +800.0% |
| Q1 2015 | $274,003,000 | +41.5% | 4,413 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $193,642,000 | -21.4% | 4,413 | +1.4% | 0.00% | 0.0% |
| Q3 2014 | $246,436,000 | +26.1% | 4,354 | +0.0% | 0.00% | 0.0% |
| Q2 2014 | $195,361,000 | – | 4,352 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |